سرمایه گذاری شفا دارو
شفا | Stocks - Tehran Stock Exchange (TSE)
سایر محصولات دارویی
Sector:
سایر محصولات دارویی
Market Type:
Stocks
Status:
Authorized
Last Price: 80,330 0.30
Close Price: 81,110
Income Statement
AGM
Interim
2026/05/10 Fiscal Year 2025/12/2112 Month | 2025/04/20 Fiscal Year 2024/12/2012 Month | 2024/05/26 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | - | 3.395 Trillion | 4.134 Trillion | |
Total Revenues | 6.019 Trillion | 3.395 Trillion | 4.134 Trillion | |
Gross Profit | 6.019 Trillion | 3.395 Trillion | 4.134 Trillion | |
General & Administrative Expenses | 459.242 Billion | 281.056 Billion | 296.854 Billion | |
Operating Profit (Loss) | 5.56 Trillion | 3.114 Trillion | 3.837 Trillion | |
Profit Before Tax | 5.698 Trillion | 3.222 Trillion | 4.037 Trillion | |
Tax | 2.965 Billion | 3.759 Billion | - | |
Net Profit (Loss) After Tax | 5.695 Trillion | 3.218 Trillion | 4.037 Trillion | |
Retained Earnings at Beginning of Period | 6.167 Trillion | 5.787 Trillion | 8.123 Trillion | |
Approved Dividends — Prior Year AGM | -1.595 Trillion | -2.838 Trillion | -5.695 Trillion | |
Allocable Profit | 10.268 Trillion | 6.167 Trillion | 6.464 Trillion | |
Approved Dividends — Current Year | 4.61 Trillion | 1.6 Trillion | 2.848 Trillion | |
Retained Earnings at End of Period | 5.657 Trillion | 4.567 Trillion | 2.939 Trillion | |
درآمد سود سهام | 6.019 Trillion | - | - | |
اندوخته سرمایهای مصوب | - | - | 677.837 Billion |